Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry.

Binding sites on human serum albumin (HSA) for anionic drugs and fatty acids have been thermodynamically characterized by microcalorimetry. The binding and the thermodynamic parameters were directly computed from the calorimetric titration data at 37 degrees C in a phosphate buffer (pH 7.4) using one- and two-class binding models. From compensation analyses plotting the molar enthalpy change (delta Hm,i) versus those of the molar free energy (delta Gm,i) and molar entropy (delta Sm,i) for each class of binding sites, HSA binding sites were classified into groups S1, S2, and S3. Group S1 included high-affinity binding sites for site II-bound drugs, such as ibuprofen, flufenamic acid, and ethacrynic acid, and short- or medium-length alkyl-chain fatty acids; group S2 included low-affinity binding sites of site II-bound drugs and long-length alkyl-chain fatty acids; and group S3 contained the high-affinity binding sites for site I-bound drugs, such as phenylbutazone, oxphenbutazone, and warfarin, and long-length alkyl-chain fatty acids. High- and low-affinity bindings sites for salicylic acid and acetylaslicylic acid agreed with the regions of groups S3 and S2, respectively. Groups S1 and S2 were characterized by large negative values of delta Hm,i and delta Sm,i, reflecting van der Waals interaction and hydrogen-bonding formation in low dielectric media, and the main force to stabilize the binding complex in group S3 was a hydrophobic interaction, characterized by a small negative delta Hm,i and minor or positive values of delta Sm,i (entropy-driven).

[1]  D C Carter,et al.  Structure of human serum albumin. , 1990, Science.

[2]  D. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1992, Nature.

[3]  W. Müller,et al.  Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. , 1982, Molecular pharmacology.

[4]  A. Rosén,et al.  The Existence of Conformationally Labile (Preformed) Drug Binding Sites in Human Serum Albumin as Evidenced by Optical Rotation Measurements , 1993, The Journal of pharmacy and pharmacology.

[5]  G. Sudlow,et al.  Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.

[6]  T. Hirokawa,et al.  Isotachophoretic determination of mobility and pKa by means of computer simulation : II. Evaluation of mo and pKa of 65 anions , 1982 .

[7]  M. Galliano,et al.  High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. , 1992, Biochemical pharmacology.

[8]  A. O. Pedersen,et al.  Laurate binding to human serum albumin. Multiple binding equilibria investigated by a dialysis exchange method. , 1986, European journal of biochemistry.

[9]  R. Brodersen,et al.  Detection of carrier heterogeneity by rate of ligand dialysis: medium-chain fatty acid interaction with human serum albumin and competition with chloride. , 1988, Analytical biochemistry.

[10]  A. Bertuzzi,et al.  Sebacic acid binding to human plasma albumin. , 1993, Biochemical pharmacology.

[11]  J. Vallner Binding of drugs by albumin and plasma protein. , 1977, Journal of pharmaceutical sciences.

[12]  W. G. Hunter,et al.  Enthalpy-entropy compensation. 1. Some fundamental statistical problems associated with the analysis of van't Hoff and Arrhenius data , 1976 .

[13]  L. Janssen,et al.  Thermodynamics of the interaction of benzodiazepines with human serum albumin , 1990 .

[14]  R. C. Weast CRC Handbook of Chemistry and Physics , 1973 .

[15]  H. Aki,et al.  Drug binding to human erythrocytes in the process of ionic drug-induced hemolysis. Flow microcalorimetric approaches. , 1991, Biochemical pharmacology.

[16]  D. Grant,et al.  Enthalpy—entropy compensation in pharmaceutical solids , 1987 .

[17]  M R Eftink,et al.  Enthalpy-entropy compensation and heat capacity changes for protein-ligand interactions: general thermodynamic models and data for the binding of nucleotides to ribonuclease A. , 1983, Biochemistry.

[18]  H. Aki,et al.  Biothermodynamic characterization of monocarboxylic and dicarboxylic aliphatic acids binding to human serum albumin: a flow microcalorimetric study. , 1993, Biophysical chemistry.

[19]  P. Ross,et al.  Thermodynamics of protein association reactions: forces contributing to stability. , 1981, Biochemistry.

[20]  E. Tomlinson Enthalpy-entropy compensation analysis of pharmaceutical, biochemical and biological systems , 1983 .

[21]  H. Aki,et al.  Thermodynamics of the Binding of Phenothiazines to Human Plasma, Human Serum Albumin and α1‐Acid Glycoprotein: A Calorimetric Study , 1989, The Journal of pharmacy and pharmacology.

[22]  I M Klotz,et al.  PHYSICOCHEMICAL ASPECTS OF DRUG‐PROTEIN INTERACTIONS: A GENERAL PERSPECTIVE , 1973, Annals of the New York Academy of Sciences.

[23]  U Kragh-Hansen,et al.  Molecular aspects of ligand binding to serum albumin. , 1981, Pharmacological reviews.

[24]  P. Brooks,et al.  Structural requirements for drug binding to site II on human serum albumin. , 1983, Molecular pharmacology.

[25]  J. Fletcher,et al.  Medium chain fatty acid binding to human plasma albumin. , 1972, The Journal of biological chemistry.

[26]  J. Miñones,et al.  Spectrofluorimetric study of the binding of 1-anilinonaphthalene-8-sulfonate to bovine serum albumin. , 1992, Journal of pharmaceutical sciences.

[27]  K. Fehske,et al.  A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin. , 1979, Biochimica et biophysica acta.

[28]  H. Aki,et al.  Application of differential flow microcalorimetry for study of drug interactions in the blood system. , 1988, Journal of Biochemical and Biophysical Methods.

[29]  J. Freed,et al.  ESR studies of stearic acid binding to bovine serum albumin. , 1990, Biochimica et biophysica acta.

[30]  I. Sjöholm,et al.  Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. , 1979, Molecular pharmacology.

[31]  A. A. Spector,et al.  Long chain fatty acid binding to human plasma albumin. , 1975, The Journal of biological chemistry.